2395 SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.新日本科学TSE Prime / Services
0 posts
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) Stock Price HistoryNear a 52-week low
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. closed at ¥1,110 on Nov 20, 2026, −20.8% over 1 month, −31.9% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥79,173 today (−20.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −20.8%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥1,110 | −38 | −3.31% |
| Nov 19 (Thu) | ¥1,148 | −9 | −0.78% |
| Nov 18 (Wed) | ¥1,157 | −18 | −1.53% |
| Nov 17 (Tue) | ¥1,175 | −40 | −3.29% |
| Nov 16 (Mon) | ¥1,215 | −24 | −1.94% |
| Nov 13 (Fri) | ¥1,239 | +10 | +0.81% |
| Nov 12 (Thu) | ¥1,229 | +28 | +2.33% |
| Nov 11 (Wed) | ¥1,201 | −39 | −3.15% |
| Nov 10 (Tue) | ¥1,240 | −210 | −14.48% |
| Nov 9 (Mon) | ¥1,450 | +88 | +6.46% |
If you had invested ¥100,000 3 months ago, it would be worth ¥75,665 today (−24.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −24.3%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥1,110 | −38 | −3.31% |
| Nov 19 (Thu) | ¥1,148 | −9 | −0.78% |
| Nov 18 (Wed) | ¥1,157 | −18 | −1.53% |
| Nov 17 (Tue) | ¥1,175 | −40 | −3.29% |
| Nov 16 (Mon) | ¥1,215 | −24 | −1.94% |
| Nov 13 (Fri) | ¥1,239 | +10 | +0.81% |
| Nov 12 (Thu) | ¥1,229 | +28 | +2.33% |
| Nov 11 (Wed) | ¥1,201 | −39 | −3.15% |
| Nov 10 (Tue) | ¥1,240 | −210 | −14.48% |
| Nov 9 (Mon) | ¥1,450 | +88 | +6.46% |
If you had invested ¥100,000 6 months ago, it would be worth ¥88,095 today (−11.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −11.9%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥1,110 | −26.3% |
| Oct 2026 | ¥1,506 | +13.6% |
| Sep 2026 | ¥1,326 | −4.4% |
| Aug 2026 | ¥1,387 | +8.6% |
| Jul 2026 | ¥1,277 | +10.8% |
| Jun 2026 | ¥1,153 | −5.3% |
| May 2026 | ¥1,217 | −15.0% |
If you had invested ¥100,000 1 year ago, it would be worth ¥68,056 today (−31.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −31.9%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥1,110 | −26.3% |
| Oct 2026 | ¥1,506 | +13.6% |
| Sep 2026 | ¥1,326 | −4.4% |
| Aug 2026 | ¥1,387 | +8.6% |
| Jul 2026 | ¥1,277 | +10.8% |
| Jun 2026 | ¥1,153 | −5.3% |
| May 2026 | ¥1,217 | −15.0% |
| Apr 2026 | ¥1,432 | +1.3% |
| Mar 2026 | ¥1,414 | −17.0% |
| Feb 2026 | ¥1,703 | +5.3% |
| Jan 2026 | ¥1,617 | −3.3% |
| Dec 2025 | ¥1,672 | −8.3% |
| Nov 2025 | ¥1,823 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥66,071 today (−33.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −33.9%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,110 | −33.6% |
| 2025 | ¥1,672 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥64,385 today (−35.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −35.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,110 | −33.6% |
| 2025 | ¥1,672 | ― |
If you had invested ¥100,000 in Apr 2004, it would be worth ¥91,736 today (−8.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +375.9%, while this stock moved −8.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥1,110 | −33.6% |
| 2025 | ¥1,672 | +0.2% |
| 2024 | ¥1,668 | −1.8% |
| 2023 | ¥1,698 | −24.9% |
| 2022 | ¥2,260 | +59.2% |
| 2021 | ¥1,420 | +110.4% |
| 2020 | ¥675 | +7.0% |
| 2019 | ¥631 | −5.8% |
| 2018 | ¥670 | +15.7% |
| 2017 | ¥579 | −1.2% |
| 2016 | ¥586 | +41.2% |
| 2015 | ¥415 | −47.5% |
| 2014 | ¥791 | −40.7% |
| 2013 | ¥1,335 | +326.5% |
| 2012 | ¥313 | +59.7% |
| 2011 | ¥196 | −49.2% |
| 2010 | ¥386 | −29.8% |
| 2009 | ¥550 | −22.3% |
| 2008 | ¥708 | −58.4% |
| 2007 | ¥1,703 | −20.6% |
| 2006 | ¥2,145 | +9.9% |
| 2005 | ¥1,951 | +390.8% |
| 2004 | ¥398 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2004). Please check the latest prices before trading.
SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395)
Business overview
Together with 26 consolidated subsidiaries and 7 affiliates, the company runs CRO, translational research (TR), Medipolis and other businesses. In the CRO business, it takes on non-clinical studies, clinical trials and new drug applications for pharmaceutical companies and others, with its safety research laboratory and subsidiary 「新日本科学イナリサーチセンター」 handling non-clinical studies and sample analysis and 「新日本科学PPD」 handling clinical development. The TR business researches and develops its own nasal delivery platform technology, SMART, and nurtures, commercializes and invests in knowledge from universities and biotech ventures. It has spun out companies such as Satsuma Pharmaceuticals, Inc. in the US from this technology, and Satsuma's nasal migraine treatment Atzumi received US FDA approval in April 2025. The Medipolis business runs geothermal power generation, accommodation and other operations on its site in Ibusuki City, Kagoshima Prefecture.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Services (532 companies)
| Dividend yield | 4.50% | No. 94 in the sector (highest first); median 3.40% |
|---|---|---|
| PER | 13.2x | Above the sector median of 12.9x (No. 227 from the lowest) |
| PBR | 1.17x | Below the sector median of 1.49x (No. 181 from the lowest) |
| ROE | 8.87% | No. 300 in the sector (highest first); median 12.16% |
| Market cap | ¥46.2 bn | No. 91 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥1,952 | 2025/12/11 |
|---|---|---|
| 52-week low | ¥1,079 | 6/15 |
| Current position | 3.6% | Where the low is 0% and the high is 100% (close on 11/20: ¥1,110) |
| Year to date | -33.6% | No. 450 of 524 in the sector (best first) |
| 1 year | -31.9% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 10/6 (No. 18) |
|---|---|---|
| Top 50 losers | 1 times | Latest: 11/10 (No. 5) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/10 11:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 11/10 11:30剰余金の配当に関するお知らせ
- 11/10 11:302027年3月期 第2四半期決算説明資料(決算説明会資料)
- 11/10 11:30新中期経営計画:Transformation 2030(決算説明会資料)
Filings from the past 12 months (4).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. board
More Japanese stocks in English
- Balleggs Co.,Ltd.239A
- TETSUJIN Holdings,Inc.2404
- KG Intelligence CO.,LTD.2408
- CAREER DESIGN CENTER CO.,LTD.2410
- GENDAI AGENCY INC.2411
- Human Holdings Co.,Ltd.2415
- TSUKADA GLOBAL HOLDINGS Inc.2418
- ROXX,inc.241A
- Brass Corporation2424
- Care Service Co.,Ltd.2425
- WELLNET CORPORATION2428
- WORLD HOLDINGS CO.,LTD.2429